Annual EBITDA
-$41.69 M
+$26.09 M+38.49%
December 31, 2023
Summary
- As of February 7, 2025, VINC annual EBITDA is -$41.69 million, with the most recent change of +$26.09 million (+38.49%) on December 31, 2023.
- During the last 3 years, VINC annual EBITDA has fallen by -$30.98 million (-289.15%).
- VINC annual EBITDA is now -289.15% below its all-time high of -$10.71 million, reached on December 31, 2020.
Performance
VINC EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$7.52 M
-$422.00 K-5.95%
September 30, 2024
Summary
- As of February 7, 2025, VINC quarterly EBITDA is -$7.52 million, with the most recent change of -$422.00 thousand (-5.95%) on September 30, 2024.
- Over the past year, VINC quarterly EBITDA has dropped by -$2.24 million (-42.52%).
- VINC quarterly EBITDA is now -187850.00% below its all-time high of -$4000.00, reached on March 31, 2020.
Performance
VINC Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$27.10 M
+$1.84 M+6.35%
September 30, 2024
Summary
- As of February 7, 2025, VINC TTM EBITDA is -$27.10 million, with the most recent change of +$1.84 million (+6.35%) on September 30, 2024.
- Over the past year, VINC TTM EBITDA has increased by +$14.59 million (+35.00%).
- VINC TTM EBITDA is now -677475.00% below its all-time high of -$4000.00, reached on March 31, 2020.
Performance
VINC TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
VINC EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +38.5% | -42.5% | +35.0% |
| 3 y3 years | -289.1% | +64.9% | +63.4% |
| 5 y5 years | - | - | - |
VINC EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +38.5% | -42.5% | +64.9% | at high | +63.8% |
| 5 y | 5-year | -289.1% | +38.5% | <-9999.0% | +64.9% | <-9999.0% | +63.8% |
| alltime | all time | -289.1% | +38.5% | <-9999.0% | +64.9% | <-9999.0% | +63.8% |
Vincerx Pharma EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$7.52 M(+5.9%) | -$27.10 M(-6.3%) |
| Jun 2024 | - | -$7.10 M(-1.6%) | -$28.94 M(-14.0%) |
| Mar 2024 | - | -$7.21 M(+36.8%) | -$33.65 M(-19.3%) |
| Dec 2023 | -$41.69 M(-38.5%) | -$5.28 M(-43.6%) | -$41.69 M(-15.3%) |
| Sep 2023 | - | -$9.36 M(-20.8%) | -$49.22 M(-10.9%) |
| Jun 2023 | - | -$11.81 M(-22.6%) | -$55.22 M(-10.4%) |
| Mar 2023 | - | -$15.25 M(+19.2%) | -$61.64 M(-9.1%) |
| Dec 2022 | -$67.78 M | -$12.80 M(-16.6%) | -$67.78 M(-6.3%) |
| Sep 2022 | - | -$15.36 M(-15.8%) | -$72.35 M(-3.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2022 | - | -$18.23 M(-14.8%) | -$74.88 M(+1.1%) |
| Mar 2022 | - | -$21.40 M(+23.2%) | -$74.04 M(+18.9%) |
| Dec 2021 | -$62.32 M(+481.6%) | -$17.36 M(-2.9%) | -$62.27 M(+12.6%) |
| Sep 2021 | - | -$17.88 M(+2.8%) | -$55.27 M(+46.6%) |
| Jun 2021 | - | -$17.39 M(+80.7%) | -$37.70 M(+85.4%) |
| Mar 2021 | - | -$9.63 M(-7.2%) | -$20.34 M(+89.8%) |
| Dec 2020 | -$10.71 M | -$10.37 M(+3300.7%) | -$10.71 M(+3032.7%) |
| Sep 2020 | - | -$305.00 K(+824.2%) | -$342.00 K(+824.3%) |
| Jun 2020 | - | -$33.00 K(+725.0%) | -$37.00 K(+825.0%) |
| Mar 2020 | - | -$4000.00 | -$4000.00 |
FAQ
- What is Vincerx Pharma annual EBITDA?
- What is the all time high annual EBITDA for Vincerx Pharma?
- What is Vincerx Pharma annual EBITDA year-on-year change?
- What is Vincerx Pharma quarterly EBITDA?
- What is the all time high quarterly EBITDA for Vincerx Pharma?
- What is Vincerx Pharma quarterly EBITDA year-on-year change?
- What is Vincerx Pharma TTM EBITDA?
- What is the all time high TTM EBITDA for Vincerx Pharma?
- What is Vincerx Pharma TTM EBITDA year-on-year change?
What is Vincerx Pharma annual EBITDA?
The current annual EBITDA of VINC is -$41.69 M
What is the all time high annual EBITDA for Vincerx Pharma?
Vincerx Pharma all-time high annual EBITDA is -$10.71 M
What is Vincerx Pharma annual EBITDA year-on-year change?
Over the past year, VINC annual EBITDA has changed by +$26.09 M (+38.49%)
What is Vincerx Pharma quarterly EBITDA?
The current quarterly EBITDA of VINC is -$7.52 M
What is the all time high quarterly EBITDA for Vincerx Pharma?
Vincerx Pharma all-time high quarterly EBITDA is -$4000.00
What is Vincerx Pharma quarterly EBITDA year-on-year change?
Over the past year, VINC quarterly EBITDA has changed by -$2.24 M (-42.52%)
What is Vincerx Pharma TTM EBITDA?
The current TTM EBITDA of VINC is -$27.10 M
What is the all time high TTM EBITDA for Vincerx Pharma?
Vincerx Pharma all-time high TTM EBITDA is -$4000.00
What is Vincerx Pharma TTM EBITDA year-on-year change?
Over the past year, VINC TTM EBITDA has changed by +$14.59 M (+35.00%)